Russia’s Federal Medical-Biological Agency (FMBA) head Veronika Skvortsova announced that their cancer vaccine Enteromix is now available for clinical use.
Enteromix is Developed by the National Medical Research Radiological Centre (NMRRC) and the Engelhardt Institute of Molecular Biology ins Moscow, Russia.
This vaccine and cure approach is said to have no major side effects unlike chemotherapy and radiation.
This vaccine boasts a similar approach used in some covid-19 vaccines called mRNA technology, eliminating the need of using weakened virus and boosting the cells of our body to activate immune response against cancer cells.
There is 60-80% shrinkage of cancer tumors shown in tests and trials by the Enteromix, with also improved survival rates of the test subjects.
Russia is being praised for such a major milestone in ridding the world of cancer, with the oncovaccine on its way for regulatory clearance with high hopes of getting approved.
Enteromix will also be free for cancer patients not only in Russia but also in the whole world.
